Farms.com Home   Ag Industry News

Monsanto, Bayer announce cross-licensing deal

Rival biotech companies to Share Plant Biotechnology

By , Farms.com

Monsanto Co. and competitor Bayer CropScience announced on Tuesday that they have signed a series of cross-licensing agreements to share various crop biotechnologies for weed and pest control.

Monsanto is granting Bayer royalty-bearing licences for its Genuity Roundup Ready 2 Yield and Genuity Roundup Ready 2 Xtend technology for soybeans in the U.S. and Canada. In turn, Bayer is granting Monsanto licences to its technologies for controlling corn rootworm.

Monsanto and other agricultural biotech companies have been working on developing new chemicals to tackle weed resistance, which has become a problem with the expansion of Roundup resistant weeds and insects. Financial terms of the deals were not disclosed.


Trending Video

A new era in biostimulants and bionutritionals

Video: A new era in biostimulants and bionutritionals


In response to the growing need for efficient, effective biosolutions, HGS BioScience continues to expand its footprint in the bionutritional and biostimulant market with the acquisition of NutriAg, Ltd. The Paine Schwartz Partners-backed HGS BioScience is a global leader in humic and fulvic acid products. Toronto-based NutriAg is an innovator in bionutritional technologies with a deep R&D engine. North American growers and retailers will benefit from:

• Solutions across the biostimulant spectrum - including humics, fulvics, bionutritionals, carbohydrate chelation, amino acids, plant and seaweed extracts, and microbial technologies.
• A portfolio and R&D pipeline of science-backed solutions proven to drive crop productivity and farm profitability.
• Actionable nutrient insights and recommendations based on data specific to their farm and cropping goals with the NutriAnalytics platform